Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
Abstract Background The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface of RS and TCMs were yet to be defined. T...
Saved in:
Main Authors: | Zuanji Liang (Author), Yunfeng Lai (Author), Meng Li (Author), Junnan Shi (Author), Chi Ieong Lei (Author), Hao Hu (Author), Carolina Oi Lam Ung (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
by: Junnan Shi, et al.
Published: (2023) -
Benchmarking Drug Regulatory Systems for Capacity Building: An Integrative Review of Tools, Practice, and Recommendations
by: Junnan Shi, et al.
Published: (2023) -
Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials
by: Zuanji Liang, et al.
Published: (2021) -
An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review
by: Junnan Shi, et al.
Published: (2019) -
Policy Interventions, Development Trends, and Service Innovations of Internet Hospitals in China: Documentary Analysis and Qualitative Interview Study
by: Yunfeng Lai, et al.
Published: (2021)